Bridget Martell MA, MD
InvestorSenior Biopharmaceutical Advisor at Two Bear Capital
Guilford, Connecticut, United States
About
Bridget Martell is a physician-scientist and biotech executive who serves as founder and managing director of BAM Consultants, LLC, providing clinical and commercial advisory services to biopharmaceutical companies. She has held chief medical officer roles at Kura Oncology and Juniper Pharmaceuticals, and served as CEO of Artizan Biosciences, a Yale University precision medicine spin-out. Dr. Martell has contributed to the development and approval of seven marketed medicines and has advised on over $3 billion in M&A and licensing transactions; she also serves as an independent board director and venture investor providing clinical due diligence for early-stage life science investments.
Experience
- BAM Consultants, LLCFounder and Managing Directorcurrent2013 — presentNew Haven, CT
- Two Bear CapitalSenior Advisorcurrent2025 — presentWhitefish, Montana, United States
- Two Bear CapitalBiotechnology Operating Partner2024 — 2025Whitefish, Montana, United States
- Memorial Sloan Kettering Cancer CenterEntrepreneur in Residencecurrent2025 — presentNew York, New York, United States
- Yale University VenturesEntrepreneur In Residencecurrent2017 — presentNew Haven, CT
- Delcath SystemsIndependent Board Directorcurrent2024 — presentUnited States
- Aligos TherapeuticsIndependent Board Directorcurrent2021 — presentSan Francisco Bay Area
- Achieve Life SciencesIndependent Board Directorcurrent2021 — presentSeattle, Washington, United States and Vancouver, British
- Ayala PharmaceuticalsIndependent Board Director2023 — 2024New Jersey; Israel
- POINT BiopharmaIndependent Board Director2023
- Artizan Biosciences, Inc.President and Chief Executive Officer2021 — 2023New Haven, Connecticut, United States
- Kura Oncology, Inc.Senior Scientific Advisor2020 — 2021Boston, Massachusetts, United States
- Kura Oncology, Inc.Acting Chief Medical Officer2020Cambridge, Massachusetts, United States
- Kura Oncology, Inc.Vice President Clinical Development2017 — 2020Boston, Massachusetts, United States
- Yale-New Haven HospitalAssociate Clinical Professor2000 — 2021New Haven, CT
- RRD International, LLCChief Medical Officer2018 — 2020Maryland, United States
- RRD International, LLCStrategic Advisor2017 — 2018
- Juniper Pharmaceuticals (formerly Columbia Labs)Chief Medical Officer and Senior Vice President Clinical Product Development2015 — 2017Boston, MA
- Pfizer PharmaceuticalsBiosimilars Medical Head2010 — 2011New York NY
- Pfizer PharmaceuticalsSenior Medical Director/Medical Lead IV Injectables Established Products Business Unit2010New York, NY
- Pfizer PharmaceuticalsMedical Director/ Team Leader Sutent GU Oncology2007 — 2010New York, NY
- Pfizer PharmaceuticalsAssociate Director/Clinical Research Physician2005 — 2007New Haven Clinical Research Unit
Skills & more
Biologics13Oncology47Product Lifecycle Management8Clinical Trials65Hospitals3Clinical Development40Pharmaceutical Industry31Internal Medicine7Cancer11Medical Affairs14Pharmacovigilance6Medicine23
+12 more
Drug DevelopmentBiotechnologyClinical ResearchRegulatory SubmissionsTreatmentTherapeutic AreasImmunologyFDAMedical WritingMarket AccessLifesciencesRegulatory AffairsFrom Bridget's professional profile.
Colleagues at Two Bear Capital
Amalia Colangelo
Principal at Two Bear Capital
Ashley Archibeque
Executive Assistant at Two Bear Capital
Avery Sonnenberg
Principal at Two Bear Capital
Bria Iuliano
Executive Assistant at Two Bear Capital
Cris Neckar
Partner at Two Bear Capital
Ellen Lubman
Biopharmaceutical Advisor at Two Bear Capital
Ellen Lubman, MBA
Biopharmaceutical Advisor at Two Bear Capital
Eric Fulton
Venture Partner at Two Bear Capital
Frequently asked questions
- Who is Bridget Martell MA, MD?
- Bridget Martell is a physician-scientist and biotech executive who serves as founder and managing director of BAM Consultants, LLC, providing clinical and commercial advisory services to biopharmaceutical companies. She has held chief medical officer roles at Kura Oncology and Juniper Pharmaceuticals, and served as CEO of Artizan Biosciences, a Yale University precision medicine spin-out. Dr. Martell has contributed to the development and approval of seven marketed medicines and has advised on over $3 billion in M&A and licensing transactions; she also serves as an independent board director and venture investor providing clinical due diligence for early-stage life science investments.
- Where does Bridget Martell MA, MD work?
- Bridget Martell MA, MD is Senior Biopharmaceutical Advisor at Two Bear Capital.
- Where did Bridget Martell MA, MD go to school?
- Bridget Martell MA, MD studied at Yale School of Medicine (Robert Wood Johnson Clinical Scholars Program, Medicine); Yale School of Medicine (Chief Resident in Internal Medicine); Yale School of Medicine (Resident in Internal Medicine).
Same school
Also attended Yale School of Medicine33
Lars PedersenPartner, Chief Financial Officer at Redpoint VenturesAlexi Nazem, MDGeneral Partner at AlleyCorpJeffrey LowPartner at Averin CapitalMax FarinaPrincipal at 5AM VenturesBrian YordyPrincipal at F-Prime Capital PartnersStephen KnightPresident & Senior Managing Partner at F-Prime Capital Partners
+ 27 more
Also attended Chicago Medical School at Rosalind Franklin U-Med & Science2
Also attended Boston University School of Medicine8
Parth DesaiPartner at Flare Capital PartnersMonica JainVenture Partner at Wavemaker Three-Sixty HealthSelene ParekhDigital Health Advisor at Excelerate Health VenturesJai ParekhDigital Health Advisor at Excelerate Health VenturesTom InselCo-Founder, Mindstrong, NIH at AIFSue SiegelHealth Moonshot Impact Board at StartUp Health
+ 2 more
Also attended Cornell University748
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerJenny LeeSenior Managing Partner at Granite AsiaNeeraj AgrawalGeneral Partner at Battery VenturesJohn ZimmerCo-founder of LyftMichelle FernandesInvestor at Index VenturesMicah RosenbloomGeneral Partner at Founder Collective
+ 742 more
Shared employers
Also worked at Two Bear Capital27
Ashley ArchibequeExecutive Assistant at Two Bear CapitalErika BoldenOperations Manager at Two Bear CapitalKevin DayPartner, Head of Capital Formation at Two Bear CapitalMeagan HennigPartner, Head of Operations at Two Bear CapitalRachel Tsunemoto Hislop, PhDPrincipal, Director of Research at Two Bear CapitalJennifer HowriganVP, Investor Relations at Two Bear Capital
+ 21 more
